mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.4 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |